Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Oral Calcium Carbonate in Parturients
NCT06650930Phase 1Completed
- Sponsor
- Stanford University
- Start
- Jan 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of calcium carbonate and calcium citrate in postpartum hemorrhage (PPH) (2 arms), sponsored by Stanford University. Primary endpoint: Ionized calcium concentration at 4 hours. Started Jan 2025; status: completed.
02
Drugs
calcium carbonatecalcium citrate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06650930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06650930.